Latest Leverage News

Connexion Mobility Ltd has agreed to acquire Hallam Road Automotive in a A$5 million deal expected to immediately lift earnings per share by up to 35% and reduce exposure to foreign exchange fluctuations.

Ragusa Minerals has started an induced polarisation geophysical survey at the Black Rock Manganese Mine within its Purple Pansy Project in Arizona, aiming to map high-grade manganese mineralisation and prepare for drilling.

Monadelphous has landed $120 million worth of new contracts spanning resources and renewable energy, including a key battery storage project for Fortescue and expanded services for Rio Tinto.

Nationwide Building Society reported a 9% rise in underlying profit to £2.026 billion for FY26, driven by market-leading mortgage growth and successful Virgin Money integration, while maintaining robust capital and liquidity positions.

Legacy Minerals has delivered a robust Scoping Study for its Mt Carrington gold-silver-copper project, confirming a high-margin 12-year operation with significant growth potential and manageable capital requirements.

Findi Limited lowers its FY26 operating revenue and EBITDA guidance, citing integration costs and funding delays, but reports operational improvements following a $25 million equity raise and appoints a new Chief Commercial Officer.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Nex Metals Explorations and the Wangkatja Tjungula Aboriginal Corporation have formalised a joint venture to combine WTAC’s capital and cultural knowledge with Nex Metals’ technical expertise to pursue gold projects in Western Australia.

Kuniko Limited’s Phase 1 drilling at the Commonwealth-Silica Hill Project delivers compelling high-grade gold, silver, and base metal results, validating extensions beyond known mineralisation and setting the stage for a larger Phase 2 program starting in July.

Island Pharmaceuticals has appointed Raymond Taylor, a former BioCryst executive with deep Galidesivir expertise and US government funding experience, to accelerate development and procurement efforts for its broad-spectrum antiviral amid rising viral threats.

AnteoTech has secured independent validation of its Ultranode™ 95 silicon anode in commercial-format battery cells, demonstrating over 40% higher energy density and strong cycle life, advancing its push into the growing drone battery market.

Vection Technologies has secured approximately $1.1 million in new orders for FY26, including a $572k extension with a classified defence partner supported by Dell Technologies and $513k in Algho AI platform contracts across four enterprise sectors.